Estados Unidos · Plataformas y datos · Morningstar

Bambusa Therapeutics Announces Pricing of Upsized Initial Public Offering

Publicado por Morningstar · Estados Unidos hace 18 h

BOSTON, Oct. 29, 2026 /PRNewswire/ -- Bambusa Therapeutics, Inc. (Nasdaq: BBTX) ("Bambusa Therapeutics" or "Bambusa"), a clinical-stage biopharmaceutical company developing…

Leer el artículo completo en Morningstar Inicie sesión para guardar

MarketNews muestra el titular y el resumen publicados por el medio. El artículo completo se lee en el sitio del editor. (www.morningstar.com)

Bambusa Therapeutics Announces Pricing of Upsized Initial Public Offering

También te puede interesar

Amazon’s and Intel’s stocks are set to plunge. But Wall Street’s October winners may surprise you.

Mastech Digital Non-GAAP EPS of $0.10 beats by $0.03, revenue of $41.99M beats by $0.45M

Best Tech Stocks Right Now

Lear stock tumbles 15% on weak revenue outlook

Smarter Braking for Electric Travel Trailers

Amazon shares are tumbling after third-quarter earnings miss. Analysts say buy the dip

Bambusa Therapeutics Announces Pricing of Upsized Initial Public Offering

Compartir

También te puede interesar

Amazon’s and Intel’s stocks are set to plunge. But Wall Street’s October winners may surprise you.

Mastech Digital Non-GAAP EPS of $0.10 beats by $0.03, revenue of $41.99M beats by $0.45M

Best Tech Stocks Right Now

Lear stock tumbles 15% on weak revenue outlook

Smarter Braking for Electric Travel Trailers

Amazon shares are tumbling after third-quarter earnings miss. Analysts say buy the dip